ULTRALIFE CORP
No SEC Form 4 filings for $ULBI in the last 30 days.
See all $ULBI insider activity →EnerSys (ENS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 EnerSys To Acquire Ultralife, Expanding Differentiated Battery Technologies and Accelerating Growth in Defense Market • Accelerates EnerSys’ growth in mission-critical defense applications particularly high growth drone and counter drone systems • Expands advanced, d
EnerSys (ENS) agreed to acquire Ultralife (ULBI) for $320 million in cash, including debt. Ultralife shareholders will receive $16.00 per share, a 166% premium over Monday's closing price. The deal, approved by both boards, is expected to close in Q1 2027. EnerSys will finance the acquisition with available cash. Both companies' CEOs cited strategic benefits and value creation.
Ultralife Corporation (ULBI) will report Q3'26 earnings on October 22. Analysts expect revenue of $56.00M and EPS of $0.23. Results are anticipated at 8:00 AM ET.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning ULBI (ULTRALIFE CORP). Coverage has skewed bullish: 3 bullish, 0 neutral, and 0 bearish.
Recent ULBI coverage spans earnings, corporate actions and financial news.
Ultralife shares may experience a sharp rise to the offer price, then settle post‑close.
Ultralife stock is expected to rise sharply to the offer price before delisting.
Guidance release may cause modest price movement.
Margin expansion and record backlog are the key near-term drivers, with additional demand and shipment timing discussed for communications and wearable batteries.
Margin expansion and higher adjusted EBITDA suggest improving profitability, but revenue is slightly down and operating expenses rose with product development and litigation-related costs.
AlphAI scores every news story that mentions ULBI with an AI model for sentiment and relevance, and aggregates insider trades from ULTRALIFE CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
EnerSys (ENS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 EnerSys To Acquire Ultralife, Expanding Differentiated Battery Technologies and Accelerating Growth in Defense Market • Accelerates EnerSys’ growth in mission-critical defense applications particularly high growth drone and counter drone systems • Expands advanced, d
2 min readEnerSys (ENS) agreed to acquire Ultralife (ULBI) for $320 million in cash, including debt. Ultralife shareholders will receive $16.00 per share, a 166% premium over Monday's closing price. The deal, approved by both boards, is expected to close in Q1 2027. EnerSys will finance the acquisition with available cash. Both companies' CEOs cited strategic benefits and value creation.
2 min readUltralife Corporation (ULBI) will report Q3'26 earnings on October 22. Analysts expect revenue of $56.00M and EPS of $0.23. Results are anticipated at 8:00 AM ET.
1 min readUltralife (ULBI) reported Q2 FY2026 revenue of $47.9 million, down 1.3% year over year, with GAAP EPS of $0.15. Gross margin rose to 28.9% on a 500 bps increase, aided by a $1.1 million IEEPA tariff refund. Backlog hit a record $117.5 million, up 39% from a year earlier, and July backlog neared $130 million.
6 min readULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ultralife Corporation Reports Second Quarter Results NEWARK, N.Y. – August 7, 2026 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: ● Sales of $47.9 million compared to $48.6 mil
6 min readUltralife Corporation (NASDAQ: ULBI) reported Q2 2026 results for the quarter ended June 30. Sales fell to $47.9 million from $48.6 million in Q2 2025. Gross profit rose to $13.9 million, with gross margin 28.9%. GAAP EPS was $0.15 vs $0.05, and adjusted EBITDA was $6.1 million vs $4.1 million. Backlog rose to $117.5 million.
4 min readULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. ulbi20260723_8k.htm false 0000875657 0000875657 2026-07-23 2026-07-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 23, 2026 Date of Report (Date of Earli
1 min readUltralife (NASDAQ:ULBI) director Bradford Whitmore bought 67,302 shares on May 26 at an average $6.81, for $458,326.62, according to an SEC filing. Post-trade, he owned 2,050,637 shares (~$13.96M). The stock trades near $7.76. On May 8, Ultralife reported Q results of -$0.03 EPS and $47.45M revenue, below consensus.
4 min readWHITMORE BRADFORD T purchased 32,876 indirectly-held shares of ULTRALIFE CORP (ULBI) at $6.13 ($0.20M total) on 2026-05-21.
1 min readThis page provides a comprehensive resource for Ultralife (ULBI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider trading forms. It highlights recent filings, such as a Form 4 detailing insider purchases by director Bradford T. Whitmore, and provides information on Ultralife's financial performance and corporate governance. The platform offers AI-generated summaries, impact scoring, and sentiment analysis for each filing.
5 min read
